Approval · Notice of Compliance 16475 · 2014
SYNTHROID: Notice of Compliance 16475
Issued December 30, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16475
- Date
- December 30, 2014
- Company
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
- Therapeutic class
- Thyroid hormone
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SYNTHROID | 02172062 | Marketed |
| SYNTHROID | 02172070 | Marketed |
| SYNTHROID | 02172089 | Marketed |
| SYNTHROID | 02172097 | Marketed |
| SYNTHROID | 02172100 | Marketed |
| SYNTHROID | 02171228 | Marketed |
| SYNTHROID | 02172119 | Marketed |
| SYNTHROID | 02233852 | Marketed |
| SYNTHROID | 02172127 | Marketed |
| SYNTHROID | 02172135 | Marketed |
| SYNTHROID | 02172143 | Marketed |
| SYNTHROID | 02172151 | Marketed |
Medicinal ingredients
- LEVOTHYROXINE SODIUM 25 MCG per TAB
- LEVOTHYROXINE SODIUM 50 MCG per TAB
- LEVOTHYROXINE SODIUM 75 MCG per TAB
- LEVOTHYROXINE SODIUM 88 MCG per TAB
- LEVOTHYROXINE SODIUM 100 MCG per TAB
- LEVOTHYROXINE SODIUM 112 MCG per TAB
- LEVOTHYROXINE SODIUM 125 MCG per TAB
- LEVOTHYROXINE SODIUM 137 MCG per TAB
- LEVOTHYROXINE SODIUM 150 MCG per TAB
- LEVOTHYROXINE SODIUM 175 MCG per TAB
- LEVOTHYROXINE SODIUM 200 MCG per TAB
- LEVOTHYROXINE SODIUM 300 MCG per TAB